Laman Utama068270 • KRX
add
Celltrion Inc
Tutup sebelumnya
₩202,000.00
Julat hari
₩194,800.00 - ₩201,500.00
Julat tahun
₩131,000.00 - ₩241,000.00
Permodalan pasaran
42.28T KRW
Bilangan Purata
641.92K
Nisbah P/E
94.85
Hasil dividen
0.26%
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (KRW) | Jun 2024info | Perubahan T/T |
|---|---|---|
Hasil | 874.74B | 66.94% |
Perbelanjaan pengendalian | 295.34B | 216.97% |
Pendapatan bersih | 78.01B | -47.11% |
Margin untung bersih | 8.92 | -68.31% |
Pendapatan bagi setiap syer | 377.00 | -63.54% |
EBITDA | 204.70B | -14.53% |
Kadar cukai berkesan | 24.71% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (KRW) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.03T | 53.19% |
Jumlah aset | 20.13T | 220.09% |
Jumlah liabiliti | 3.13T | 65.33% |
Jumlah ekuiti | 16.99T | — |
Syer tertunggak | 206.33J | — |
Harga kepada buku | 2.47 | — |
Pulangan pada aset | 0.90% | — |
Pulangan pada modal | 0.94% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (KRW) | Jun 2024info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 78.01B | -47.11% |
Tunai daripada operasi | 293.61B | 3.31% |
Tunai daripada pelaburan | 103.88B | 212.18% |
Tunai daripada pembiayaan | -246.57B | -287.43% |
Perubahan bersih dalam tunai | 157.08B | 22.54% |
Aliran tunai bebas | 102.18B | -12.49% |
Perihal
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Wikipedia
CEO
Diasaskan
2002
Tapak web
Pekerja
2,391
